Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058737) titled 'Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy of deucravacitinib in patients with psoriasis' on Aug. 8.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: other
Condition:
psoriasis
Recruitment Status: Recruiting
Phase: Not selected
Date of First Enrollment: 2024/12/01
Target Sample Size: 90
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064442
Published by HT Digital Content Services with permission from Health Daily Dig...